Twitter with us!

Article

Ophthalmology Times Europe is now on Twitter (twitter.com/OTEurope).

Ophthalmology Times Europe is now on Twitter.

For all the breaking news and latest updates, follow us on twitter.com/OTEurope. You can tweet with the OTE team, and let us know your thoughts on all the latest stories.

If you would like to have longer discussions or network with your peers, join our European Ophthalmology forum by going to oteurope.com/forum.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!
Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Related Content
A young person with short androgynous hair sits in a waiting room, looking thoughtful. Concept image for racial groups in clinical trials and representation in studies. Image credit: ©wayhome.studio – stock.adobe.com

DMO study meta-analysis illuminates how racial subgroups are underrepresented in clinical trials

Lynda Charters
April 17th 2025
Article

The study aimed to clarify how race affects visual outcomes for patients with diabetic macular oedema treated with ranibizumab

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
A phone with several social media apps on the screen. Concept image for social media usage in clinical follow-up. Image credit: ©Tada Images – stock.adobe.com

Clinicians may improve follow-up adherence by leveraging social media apps

Lynda Charters
April 16th 2025
Article

Social media smartphone application–based interventions significantly improved adherence and parental knowledge among families of children with congenital ectopia lentis

An image which shows a translucent head, with the eye, brain and optic nerve highlighted. Concept for brain-eye neurology neuroinflammation connection. Image credit: ©jitendra jadhav – stock.adobe.com

Journal of Neuroinflammation publishes data on Eleva’s lead retinal asset CPV-104

Sydney M Crago
April 16th 2025
Article

In an established animal model of age-related macular degeneration, Eleva’s recombinant human CPV-104 improved two hallmarks of the disease

Signage labaelling the Alcon Grieshaber AG facility in Schaffhausen, Switzerland. Image courtesy of Alcon.

Alcon marks 110th anniversary of Grieshaber AG site in Switzerland

Hattie Hayes
April 15th 2025
Article

Alcon acquired the historic ophthalmic instrument company in 2000

A scientist in a lab looks into a microscope, which is placed on a desk. His face is not fully visible but he wears a lab coat and sits in front of a computer. Concept image for cell therapy, stem cell research, phase 1 clinical trial, and geographic atrophy associated with age-related macular degeneration. Image credit: ©CoetzeeRising/peopleimages.com – stock.adobe.com

Eyestem Research announces positive results from phase 1 geographic atrophy trial

Martin David Harp
April 14th 2025
Article

Bangalore-based Eyestem will share more research findings on Eyecyte-RPE at this year's Association for Research in Vision and Ophthalmology meeting

© 2025 MJH Life Sciences

All rights reserved.